Phillip Schiele
Berlin, BE 13353, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD8+ T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells.
Journal: Science advances
Published: May 21, 2025
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin's lymphoma.
Journal: Journal for immunotherapy of cancer
Published: April 01, 2025
Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients.
Journal: Cells
Published: November 24, 2024
Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myeloma.
Journal: Frontiers in immunology
Published: November 22, 2024
Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILs.
Journal: Molecular therapy. Oncology
Published: November 04, 2024
Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse events.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 29, 2024
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth.
Journal: International journal of cancer
Published: February 05, 2024
Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts.
Journal: Frontiers in immunology
Published: April 09, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026